Search the Newsreel

Compared to Estimates, OPKO Health (OPK) Q2 Earnings: A Look at Key Metrics

OPKO Health (OPK) Earnings Date and Reports 2026 $OPK

OPKO Health (NASDAQ:OPK) Issues Earnings Results

OPKO Health (OPK) Reports Q2 Loss, Tops Revenue Estimates

OPK|OPKO Health Inc|Price:1.370|Chg%:+0.050

OPKO Health, Inc. Revenue Breakdown – DUS:XCY

This article provides a revenue breakdown for OPKO Health, Inc. (DUS:XCY), detailing its top-performing segments and geographical contributions. In the last year, the company generated €516.73 million, with the Diagnostics segment accounting for €315.26 million, and the United States being the largest contributor with …

OPKO Health Inc (OPK) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of OPKO Health Inc (OPK), noting its current valuation score of 7.85 within the Healthcare Providers & Services industry. It details the company's financial metrics including a P/E ratio of -4.48 and highlights that other key valuation data …

OPKO Health Sets July 27 Webcast for Results and Guidance

OPKO Health (NASDAQ: OPK) announced it will report its second-quarter 2026 operating and financial results on Monday, July 27, 2026. The company's senior management will host a conference call and webcast at 4:30 p.m. ET to discuss the results, provide a business update, and …

Here's Why You Should Retain OPK Stock in Your Portfolio for Now

OPKO Health (OPK) is poised for growth due to its BioReference restructuring, 4Kscore sales, digital expansion, and strategic partnerships, including global commercialization of RAYALDEE. While RAYALDEE and a strong pipeline contribute to optimism, the company faces risks from early-stage clinical development, continued operating losses, …

OPKO Health to Report Second Quarter 2026 Financial Results on July 27, 2026

OPKO Health, Inc. will report its second-quarter 2026 financial and operating results on Monday, July 27, 2026. Senior management will host a conference call and webcast at 4:30 p.m. ET to discuss the results, provide a business update, and offer financial guidance. Participants are …

OPKO Health (OPK) Projected to Announce Earnings on Thursday

OPKO Health (NASDAQ:OPK) is projected to announce its Q2 2026 earnings after market close on Thursday, July 30th. Analysts anticipate an EPS of ($0.08) and revenue of $131.2330 million for the quarter. The company's stock currently has a "Reduce" rating from analysts with an …

OPKO Health stock steadies as investors weigh recent earnings and pipeline progress

OPKO Health's stock is stabilizing as investors evaluate the company's recent financial performance and the progress of its diagnostic and pharmaceutical pipeline. The company is characterized by modest revenue growth, ongoing R&D investments, and efforts to improve efficiency, reflected in its operating metrics and …

OPK4048118 Bond Coupon Profile — Rate & Payments

This article provides a coupon profile for the OPK4048118 bond issued by OPKO Health, Inc. with a 3.0% interest rate maturing on February 1, 2033. It details the bond's current coupon rate and announces that the next payment is scheduled for August 3, 2026. …

OPKO Health, Inc. (NASDAQ:OPK) Given Average Recommendation of "Reduce" by Brokerages

Five brokerages have issued an average recommendation of "Reduce" for OPKO Health, Inc. (NASDAQ:OPK), with one analyst assigning a sell rating and four a hold rating. The average one-year target price for the stock is $1.55. Recent analyst adjustments include an upgrade from "sell …

OPK4020628 Bond Risk Profile

This article provides a risk profile for the OPK4020628 bond issued by OPKO Health, Inc., which has a 3.0% coupon and matures on February 1, 2033. It focuses on offering key metrics for credit risk assessment, including security level, inflation protection, and issuer ratings, …

OPK4048118 Bond Redemption Profile

This article provides a profile of the OPK4048118 bond issued by OPKO Health, Inc., detailing its redemption overview, type, date, and amount. It also mentions the importance of checking the sinking fund schedule for callable bonds. The content emphasizes accessing key redemption data for …

OPK4020628 Bond Profile — Key Metrics

This article provides a detailed profile of the OPKO Health, Inc. 3.0% 01-FEB-2033 bond, identified as OPK4020628. It highlights key financial metrics such as the issue date, maturity date, outstanding amount, and coupon rate. Additionally, it offers a brief company description of OPKO Health, …

Opko Health(OPK) Stock Options Chain | Quotes & News

The provided content is incomplete and does not allow for a summary of Opko Health's stock options chain, quotes, or news.

OPKO Health Inc (OPK) Institutional Confidence

This article analyzes the institutional confidence in OPKO Health Inc (OPK), stating its current institutional shareholding score is 3.00, placing it 55th out of 75 in the Healthcare Providers & Services industry. The institutional shareholding proportion has increased by 22.96% quarter-over-quarter, reaching 31.36%. The …

OPKO Health, Inc. Actuals & Estimates (NASDAQ:OPK)

OPKO Health (OPK) Up 17.1% Since Last Earnings Report: Can It Continue?

H.C. Wainwright reiterates Opko Health stock rating on Q1 results

OPKO Health Reports First Quarter 2026 Business Highlights and Financial Results

OPKO Health Reports Fourth Quarter 2025 Business Highlights and Financial Results

Top OPKO Health (OPK) Competitors 2026